Q&A with David Loren: Managing Patients With Pancreatic Cystic Lesions

Video

The molecular test PancraGen helps identify false negative cases that could be missed by first-line tests like imaging, cytology and fluid chemistry.

David Loren, MD, Thomas Jefferson University, shares data on the molecular test PancraGen, which helps identify false negative cases that could be missed by first-line tests like imaging, cytology and fluid chemistry.

Loren commented, "We're trying to find those molecular markers. It's a completely different scientific approach to what we call the other types of what we call 'first-line' approach".

Related Videos
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
© 2024 MJH Life Sciences

All rights reserved.